pubmed-article:15477406 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:15477406 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:15477406 | lifeskim:mentions | umls-concept:C0085590 | lld:lifeskim |
pubmed-article:15477406 | lifeskim:mentions | umls-concept:C0042514 | lld:lifeskim |
pubmed-article:15477406 | lifeskim:mentions | umls-concept:C2063326 | lld:lifeskim |
pubmed-article:15477406 | lifeskim:mentions | umls-concept:C0542559 | lld:lifeskim |
pubmed-article:15477406 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
pubmed-article:15477406 | lifeskim:mentions | umls-concept:C1710236 | lld:lifeskim |
pubmed-article:15477406 | pubmed:issue | 16 | lld:pubmed |
pubmed-article:15477406 | pubmed:dateCreated | 2004-10-19 | lld:pubmed |
pubmed-article:15477406 | pubmed:abstractText | To gain insight into the pathogenesis of right ventricular (RV) cardiomyopathy and ventricular tachycardia (VT), we determined the clinical and electroanatomic characteristics and outcome of ablative therapy in consecutive patients with (1) RV dilatation, (2) multiple left bundle-branch block (LBBB)-type VTs, and (3) an abnormal endocardial substrate defined by contiguous electrogram abnormalities. | lld:pubmed |
pubmed-article:15477406 | pubmed:language | eng | lld:pubmed |
pubmed-article:15477406 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15477406 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:15477406 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:15477406 | pubmed:month | Oct | lld:pubmed |
pubmed-article:15477406 | pubmed:issn | 1524-4539 | lld:pubmed |
pubmed-article:15477406 | pubmed:author | pubmed-author:DawidI GIG | lld:pubmed |
pubmed-article:15477406 | pubmed:author | pubmed-author:DixitSanjayS | lld:pubmed |
pubmed-article:15477406 | pubmed:author | pubmed-author:CallansDavid... | lld:pubmed |
pubmed-article:15477406 | pubmed:author | pubmed-author:MarchlinskiFr... | lld:pubmed |
pubmed-article:15477406 | pubmed:author | pubmed-author:RussoAndreaA | lld:pubmed |
pubmed-article:15477406 | pubmed:author | pubmed-author:ZadoEricaE | lld:pubmed |
pubmed-article:15477406 | pubmed:author | pubmed-author:HsiaHenryH | lld:pubmed |
pubmed-article:15477406 | pubmed:author | pubmed-author:NayakHemalH | lld:pubmed |
pubmed-article:15477406 | pubmed:author | pubmed-author:GerstenfeldEd... | lld:pubmed |
pubmed-article:15477406 | pubmed:author | pubmed-author:PulliamWardW | lld:pubmed |
pubmed-article:15477406 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:15477406 | pubmed:day | 19 | lld:pubmed |
pubmed-article:15477406 | pubmed:volume | 110 | lld:pubmed |
pubmed-article:15477406 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:15477406 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:15477406 | pubmed:pagination | 2293-8 | lld:pubmed |
pubmed-article:15477406 | pubmed:meshHeading | pubmed-meshheading:15477406... | lld:pubmed |
pubmed-article:15477406 | pubmed:meshHeading | pubmed-meshheading:15477406... | lld:pubmed |
pubmed-article:15477406 | pubmed:meshHeading | pubmed-meshheading:15477406... | lld:pubmed |
pubmed-article:15477406 | pubmed:meshHeading | pubmed-meshheading:15477406... | lld:pubmed |
pubmed-article:15477406 | pubmed:meshHeading | pubmed-meshheading:15477406... | lld:pubmed |
pubmed-article:15477406 | pubmed:meshHeading | pubmed-meshheading:15477406... | lld:pubmed |
pubmed-article:15477406 | pubmed:meshHeading | pubmed-meshheading:15477406... | lld:pubmed |
pubmed-article:15477406 | pubmed:meshHeading | pubmed-meshheading:15477406... | lld:pubmed |
pubmed-article:15477406 | pubmed:meshHeading | pubmed-meshheading:15477406... | lld:pubmed |
pubmed-article:15477406 | pubmed:meshHeading | pubmed-meshheading:15477406... | lld:pubmed |
pubmed-article:15477406 | pubmed:meshHeading | pubmed-meshheading:15477406... | lld:pubmed |
pubmed-article:15477406 | pubmed:meshHeading | pubmed-meshheading:15477406... | lld:pubmed |
pubmed-article:15477406 | pubmed:meshHeading | pubmed-meshheading:15477406... | lld:pubmed |
pubmed-article:15477406 | pubmed:meshHeading | pubmed-meshheading:15477406... | lld:pubmed |
pubmed-article:15477406 | pubmed:meshHeading | pubmed-meshheading:15477406... | lld:pubmed |
pubmed-article:15477406 | pubmed:meshHeading | pubmed-meshheading:15477406... | lld:pubmed |
pubmed-article:15477406 | pubmed:meshHeading | pubmed-meshheading:15477406... | lld:pubmed |
pubmed-article:15477406 | pubmed:meshHeading | pubmed-meshheading:15477406... | lld:pubmed |
pubmed-article:15477406 | pubmed:meshHeading | pubmed-meshheading:15477406... | lld:pubmed |
pubmed-article:15477406 | pubmed:meshHeading | pubmed-meshheading:15477406... | lld:pubmed |
pubmed-article:15477406 | pubmed:year | 2004 | lld:pubmed |
pubmed-article:15477406 | pubmed:articleTitle | Electroanatomic substrate and outcome of catheter ablative therapy for ventricular tachycardia in setting of right ventricular cardiomyopathy. | lld:pubmed |
pubmed-article:15477406 | pubmed:affiliation | Electrophysiology Section, Division of Cardiology, University of Pennsylvania Health System, Philadelphia, Pa, USA. francis.marchlinski@uphs.upenn.edu | lld:pubmed |
pubmed-article:15477406 | pubmed:publicationType | Journal Article | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15477406 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15477406 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15477406 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15477406 | lld:pubmed |